Get started
Author

Julio del Río-Garma

Observed names: J del Rio Garma, J del Río Garma, J. Del Río, J. Del Río‐Garma, J. del Río Garma, Julio Del Rio Garma, Julio Del Rio-Garma, Julio Del Río-Garma, Julio Del Río-Garma, Julio Del Río‐Garma, Julio del Rio, Julio del Rio Garma, Julio del Rio-Garma, Julio del Rio‐Garma, Julio del Río-Garma, Rio-Garma, Julio Del
ORCID: 0000-0003-4705-4666
Observed ORCID: 0000-0003-4705-4666
OpenAlex ID: A5014580964
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
2022 · Cristina Pascual Izquierdo, María Eva Mingot-Castellano, et al. · Blood Advances · 65
PDF
Methylene blue‐photoinactivated plasma vs. fresh‐frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura
2004 · A. Alvarez‐Larrán, J. Del Río, et al. · Vox Sanguinis · 65
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
2025 · Paul Coppo, Michael Bubenheim, et al. · EClinicalMedicine · 64
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study
2010 · Javier de la Rubia, Federico Moscardó, et al. · Transfusion and Apheresis Science · 64
Methylene blue‐photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study
2008 · Julio Del Río‐Garma, Alberto Alvarez‐Larrán, et al. · British Journal of Haematology · 60
Guía diagnóstica y terapéutica de las microangiopatías trombóticas del Grupo Español de Aféresis
2014 · Enric Contreras, Javier de la Rubia, et al. · Medicina Clínica · 49
PDF
Púrpura trombótica trombocitopénica
2010 · Javier de la Rubia, Enric Contreras, et al. · Medicina Clínica · 31
Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura
2021 · Cristina Pascual‐Izquierdo, Julio del Rio‐Garma, et al. · Journal of Clinical Apheresis · 28
Recomendaciones para el abordaje clínico de pacientes con púrpura trombocitopénica trombótica
2021 · María Eva Mingot Castellano, Cristina Pascual Izquierdo, et al. · Medicina Clínica · 25
Multicentric evaluation of the new HemosIL Acustar ® chemiluminescence ADAMTS13 activity assay
2020 · Cristina Pascual, Jorge M. Nieto, et al. · International Journal of Laboratory Hematology · 24
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy
2024 · María-Eva Mingot-Castellano, Faustino García-Candel, et al. · Blood · 19
Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group
2015 · Enric Contreras, Javier de la Rubia, et al. · Medicina Clínica (English Edition) · 18
Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment
2009 · Alberto Alvarez-Larrán, Julio del Río-Garma, et al. · Annals of Hematology · 16
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
2021 · Julio del Río-Garma, Sabela Bobillo, et al. · Annals of Hematology · 15
ADAMTS‐13 activity and von Willebrand factor levels in methylene blue photo‐inactivated plasma processed by either the Springe method or an ‘in house’ system
2008 · J. Del Río‐Garma, A. Pereira, et al. · Vox Sanguinis · 11
Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry ( REPTT )
2023 · I. Gómez‐Seguí, E. Francés Aracil, et al. · British Journal of Haematology · 10
Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura
2022 · María Eva Mingot Castellano, Cristina Pascual Izquierdo, et al. · Medicina Clínica (English Edition) · 8
Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments
2023 · María Eva Mingot-Castellano, Cristina Pascual Izquierdo, et al. · Transfusion and Apheresis Science · 6
Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)
2023 · PAUL Coppo, Michaël Bubenheim, et al. · Blood · 5
Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group
2019 · Maria Cristina Pascual Izquierdo, Julio Del Rio-Garma, et al. · Blood · 5
[Leukemia cutis in acute promyelocytic leukemia].
1997 · J del Río Garma, M R Varela Gómez, et al. · PubMed · 3
Effect of Caplacizumab in the Recovery of ADAMTS13 Level in Patients with Autoimmune Thrombotic Thrombocytopenic Purpura. Analysis from the Spanish Registry (REPTT)
2023 · Maria Eva Mingot, Cristina Izquierdo Pascual, et al. · Blood · 2
PDF
Caplacizumab As New Paradigm-Changing Therapy for Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (aTTP): Real-World Data from TTP Spanish Registry
2020 · Irene Garcia-Garcia, Moraima Jiménez, et al. · Blood · 2
On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain.
2019 · Arturo Pereira, Julio Del Río-Garma, et al. · Blood transfusion · 2
PDF
Methylen Blue Photoinactivated Plasma vs Fresh Frozen Plasma in Thrombotic Thrombocytopenic Purpura Treatment: A Multicentric Prospective Cohort Study.
2007 · Alberto Alvarez-Larrán, Julio Del Río-Garma, et al. · Blood · 2
Works count: 36
Citation count: 601
H-index: 14
I10-index: 16
Year
Topic
Type